| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 51.35B | 55.21B | 49.04B | 45.58B | 45.00B | 37.36B |
| Gross Profit | 25.12B | 26.45B | 23.91B | 22.76B | 22.56B | 17.85B |
| EBITDA | 13.02B | 14.48B | 12.70B | 13.45B | 13.47B | 10.26B |
| Net Income | 7.91B | 9.96B | 8.01B | 8.38B | 8.67B | 5.96B |
Balance Sheet | ||||||
| Total Assets | 93.83B | 101.05B | 92.76B | 88.59B | 79.75B | 71.61B |
| Cash, Cash Equivalents and Short-Term Investments | 22.93B | 27.93B | 23.25B | 21.59B | 22.02B | 21.50B |
| Total Debt | 2.00B | 3.87B | 3.33B | 3.20B | 3.11B | 3.56B |
| Total Liabilities | 15.44B | 15.67B | 15.26B | 16.14B | 16.36B | 14.75B |
| Stockholders Equity | 78.39B | 85.38B | 77.50B | 72.45B | 63.38B | 56.16B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 9.62B | 5.46B | 460.10M | 4.14B | 8.45B |
| Operating Cash Flow | 0.00 | 11.13B | 6.30B | 2.61B | 5.19B | 9.25B |
| Investing Cash Flow | 0.00 | -1.81B | -650.16M | -2.46B | -648.02M | -2.57B |
| Financing Cash Flow | 0.00 | -4.59B | -4.17B | -2.46B | -4.26B | -2.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥171.32B | 16.73 | ― | 1.39% | 12.59% | 26.31% | |
82 Outperform | ¥106.76B | 19.73 | ― | 0.82% | 8.60% | 28.39% | |
75 Outperform | ¥297.30B | 21.26 | ― | 2.42% | 4.46% | 23.01% | |
72 Outperform | ¥13.80B | 12.63 | ― | 3.98% | 4.54% | -17.09% | |
65 Neutral | ¥573.58B | 16.45 | ― | 2.14% | 8.18% | 23.30% | |
64 Neutral | ¥2.82T | 22.84 | 8.35% | 1.77% | 4.75% | 6.22% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |